A study looks at hormone therapy and breast cancer risk, and researchers take a closer look at marijuana use in young cancer patients.

by Marci A. Landsmann

Recommendations say that a broader group of women should be considered for BRCA mutation testing, and the U.S. Food and Drug Administration issues a proposal to require that cigarettes come with graphic warnings.

by Kate Yandell

A radiation oncologist draws on her personal experience as she researches financial toxicity, and the U.S. Food and Drug Administration issues a third tissue-agnostic approval.

by Kate Yandell

A liquid biopsy test is effective in detecting a cancer biomarker, Medicare opts to cover CAR-T cell therapies, and an e-cigarette maker spends millions to defeat a ban on sales in San Francisco.

by Kevin McLaughlin

The U.S. Food and Drug Administration for the first time approves an immune checkpoint inhibitor for treatment of esophageal cancer, and a two-drug combination shows promise for treating chronic lymphocytic leukemia.

by Kate Yandell

The U.S. Food and Drug Administration requests a recall of textured breast implants, and a study indicates BRCA2 mutations are associated with non-Hodgkin lymphoma.

by Kate Yandell

A study sheds light on the effects of hurricanes on cancer patients receiving radiation therapy, and the Biden Cancer Initiative suspends operations.

by Kate Yandell and Bradley Jones

A combination of three targeted therapies can lengthen survival for some patients with metastatic colorectal cancer, and patients receiving stem cell transplants can benefit from shingles vaccines.

by Kate Yandell

A study indicates that many African Americans who could benefit from lung cancer screening are not eligible, and an oncologist writes about his experiences with medical aid in dying.

by Kate Yandell

A study shows that more than a third of U.S. cancer survivors experience chronic pain, and the U.S. Food and Drug Administration approves another immunotherapy for treatment of small cell lung cancer.

by Kate Yandell